The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone m
about
The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone m
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The risk of residual molecular ...... tem cells compared with bone m
@en
The risk of residual molecular ...... tem cells compared with bone m
@nl
type
label
The risk of residual molecular ...... tem cells compared with bone m
@en
The risk of residual molecular ...... tem cells compared with bone m
@nl
prefLabel
The risk of residual molecular ...... tem cells compared with bone m
@en
The risk of residual molecular ...... tem cells compared with bone m
@nl
P2093
P1433
P1476
The risk of residual molecular ...... ells compared with bone marrow
@en
P2093
Elmaagacli AH
Schaefer UW
P304
P407
P577
1999-07-01T00:00:00Z